News Releases

Mar 07, 2022
Lyra Therapeutics Appoints Jim Tobin to Board of Directors
Biopharmaceutical leader brings decades of expertise with C-suite tenures at Boston Scientific, Biogen and Baxter International WATERTOWN, Mass. , March 7, 2022 /PRNewswire/ -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform
Additional Formats
Feb 17, 2022
Lyra Therapeutics Appoints Harlan W. Waksal, MD, as Executive Chairman
Recent President and Chief Executive Officer of Kadmon brings vast experience leading and scaling late-stage and commercial biopharmaceutical companies WATERTOWN, Mass. , Feb. 17, 2022 /PRNewswire/ -- Lyra Therapeutics today announced the appointment of Harlan W. Waksal MD, as Executive Chairman.
Additional Formats
Displaying 11 - 14 of 14
Print Page
Email Alerts
RSS Feeds
Contact IR
Search
Back to Top